ReviewBioengineering (Basel, Switzerland)2025
Advances in Achilles Tendon Tissue Engineering: Integrating Cells, Scaffolds, and Mechanical Loading for Functional Regeneration.
Review in Bioengineering (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Biglycan Reconstitutes a Neonatal ECM Signaling Microenvironment to Drive Stem Cell-Mediated Tendon Regeneration via a Scaffold-Free Cell Sheet Platform.International journal of molecular sciences · 2026Article
- Edema and Structural Remodeling in Equine Suspensory Ligament Injury: A Severity Gradient Associated with Microvascular Dysfunction.Animals : an open access journal from MDPI · 2026Article
- Comparative analysis of different macromolecular crowding agents in human tenocyte cultures.Biomaterials and biosystems · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Achilles tendon injuries are among the most frequent and debilitating musculoskeletal conditions, often resulting in incomplete healing and functional deficits. Conventional repair techniques primarily restore structural continuity but rarely achieve full biomechanical or histological regeneration. Recent advances in tissue engineering have introduced innovative strategies combining biomimetic scaffolds, cellular therapy, growth factors, and mechanical loading to promote regenerative rather than fibrotic repair. This review summarises the current understanding of Achilles tendon biology and healing mechanisms, with a focus on the integration of stem cell technologies, scaffold design, and mechanobiological conditioning. Various scaffold systems, including natural, synthetic, hybrid, and hydrogel-based constructs, are evaluated for their biocompatibility, mechanical performance, and tenoinductive potential. Preclinical studies demonstrate that mesenchymal stem cell (MSC)-loaded scaffolds exhibit significantly enhanced biomechanical outcomes in tendon defect models, including improved tensile strength, organized collagen I deposition and aligned fibre architecture in repaired constructs. While preclinical results are promising, clinical translation remains limited by regulatory, economic, and methodological challenges. Future research should prioritise standardised protocols, long-term functional outcomes, and interdisciplinary collaboration.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.